Geneva Advisors’s Imperva, Inc. IMPV Stock Holding History

Geneva Advisors’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,110	Closed	-$772K	–	833
2016 Q4	$772K	Buy	20,110 +422	+2%	+$17.1K	0.02%	406
2016 Q3	$1.06M	Buy	19,688 +203	+1%	+$9.42K	0.02%	304
2016 Q2	$838K	Buy	19,485 +4,762	+32%	+$200K	0.02%	340
2016 Q1	$744K	Sell	14,723 -10,308	-41%	-$496K	0.02%	353
2015 Q4	$1.58M	Sell	25,031 -24,717	-50%	-$1.68M	0.03%	232
2015 Q3	$3.26M	Buy	49,748 +22,630	+83%	+$1.5M	0.07%	146
2015 Q2	$1.84M	Buy	27,118 +8,165	+43%	+$451K	0.03%	215
2015 Q1	$809K	Buy	18,953 +14,003	+283%	+$623K	0.01%	339
2014 Q4	$245K	Buy	+4,950	New	+$198K	﹤0.01%	561
2014 Q2	–	Sell	-12,585	Closed	-$701K	–	745
2014 Q1	$701K	Buy	+12,585	New	+$724K	0.01%	336

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Geneva Advisors's IMPV Position: Q1 2017 in Review

Geneva Advisors sold out of Imperva, Inc. (IMPV) in Q1 2017, closing a stake of 20,110 shares — an estimated $772K sold.

Geneva Advisors first reported a position in IMPV in Q1 2014 and held it in 10 quarters. The position peaked at $3.26M in Q3 2015. 182 funds tracked by Wall St. Rank hold IMPV as of Q1 2017.

Geneva Advisors reported no remaining Imperva, Inc. position as of Q1 2017 after selling out during the quarter.
Geneva Advisors sold 20,110 Imperva, Inc. shares in Q1 2017, an estimated $772K.
Geneva Advisors first reported a position in Imperva, Inc. in Q1 2014 and held it in 10 quarters.
Geneva Advisors's Imperva, Inc. position peaked at $3.26M in Q3 2015.
182 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2017.

Based on Geneva Advisors's 13F filing for Q1 2017, filed 1 May 2017.